Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With c-KIT Gene-mutant Rectal GIST: an Open-label, Single-arm, Phase III Trial PIRKER
Latest Information Update: 03 Aug 2023
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours; Rectal cancer
- Focus Therapeutic Use
- Acronyms PIRKER
Most Recent Events
- 03 Aug 2023 New trial record